BMY
Bristol-Myers Squibb Company
Bristol-Myers Squibb Company historical holders
total: 20
Scion Asset Management Bristol-Myers Squibb Company transactions over time
- Total transactions:
- 2
- New positions:
- 1
- Sold out:
- 1
- Held since:
- 2021 Q4
- Held for:
- 2 quarters
- Latest activity:
- 2022 Q2
Michael Burry has been an institutional investor in Bristol-Myers Squibb Company (BMY) since 2021 Q4. According to 2025 Q3 report, Michael Burry doesn't hold any shares. The fund/company first acquired BMY in 2021 Q4, initially purchasing 300,000 shares. Since the initial investment, Scion Asset Management has made 1 more transaction in this position.
When did Michael Burry exit their BMY position?
Michael Burry no longer holds Bristol-Myers Squibb Company (BMY). They sold off their entire position in 2022 Q2, closing out an investment that began in 2021 Q4.
When did Michael Burry first invest in BMY?
Michael Burry first invested in Bristol-Myers Squibb Company (BMY) in 2021 Q4 at the reported quarter-end price of $62.35 per share, acquiring 300,000 shares in their initial purchase.
What is Michael Burry's average cost basis for BMY?
Based on historical transaction data, Michael Burry's estimated cost basis for Bristol-Myers Squibb Company (BMY) is approximately $62.35 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $62.35
- Weighted AVG sell price:
- $73.03
BMY transactions history by Scion Asset Management
2 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2022 Q2
|
0.00%
|
0
|
$73.03
|
|
-100% (-300,000)
|
-13.25%
|
|
2021 Q4
|
25.12%
|
300,000
|
$62.35
|
$18,705,000
|
new
|
+25.12%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.